Skip to main content
Caplight Logo









Migrevention OÜ

Migrevention OÜ

Private
TallinnHealthcare & Life Scienceshttps://migrevention.com/

Last Round

Grant

Feb 1, 2023

Total Funding Raised

$1.03M

Company Overview

Migrevention OÜ is a digital health company that provides a software-based medical device platform for the diagnosis, monitoring, and treatment of migraine and chronic headache patients.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Medical Devices, Patient Engagement, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Freemium

AI Layer

Non-AI

Keywords

digital healthdigital headache clinicmigraine managementremote patient monitoringtelemedicineSaMDsoftware as a medical devicepatient engagementdigital care pathwaymHealthvertical SaaSheadache trackerclinical dashboardhealth tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Migrevention OÜ Comparables

Compare Migrevention OÜ with similar companies based on industry and business-model similarity.

Migrevention OÜ comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cascador Health
79%
Neura Health
77%
Curelator, LLC
76%

Migrevention OÜ Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 1, 2023
Pre SeedJan 3, 2022
GrantJun 1, 2021
GrantJun 1, 2020

Key People

Founding team and executive leadership

Katrina Laks

Chief Executive Officer

Executive Team

Migrevention OÜ Investors

Notable investors and investment history

Migrevention OÜ investors
InvestorRounds
European Regional Development FundGrant
Health FoundersPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 1, 2023

    Secured $159K in grant funding.

  • Jun 1, 2020

    $85K grant from European Regional Development Fund.

Migrevention OÜ Filings

Explore SEC and related filing metadata, where available.

Migrevention OÜ filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Migrevention OÜ's valuation, stock price, and market status.

Is Migrevention OÜ a public or private company?

Migrevention OÜ is a private company.

What is the current stock price of Migrevention OÜ?

Migrevention OÜ is a private company with no public stock price. Caplight tracks Migrevention OÜ's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is Migrevention OÜ worth (valuation)?

Valuation information for Migrevention OÜ is not publicly available.

Can I buy Migrevention OÜ stock?

Migrevention OÜ shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Migrevention OÜ's last funding round?

Migrevention OÜ's most recent funding round was Grant on February 1, 2023.

Who are the main investors in Migrevention OÜ?

Key investors in Migrevention OÜ include European Regional Development Fund, Health Founders.

Will Migrevention OÜ IPO soon?

No public IPO plans have been announced for Migrevention OÜ.

How can I track Migrevention OÜ secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Migrevention OÜ's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTallinn
Employee Range10
Year Founded2020
Last FundingFeb 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?